Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/120433
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGarcia Alcántara, Beatriz G.-
dc.contributor.authorPerelló Alomar, Catalina-
dc.contributor.authorMoreno Centeno, Elena-
dc.contributor.authorModamio Charles, Pilar-
dc.contributor.authorMariño Hernández, Eduardo L.-
dc.contributor.authorDelgado Sánchez, Olga-
dc.date.accessioned2018-03-05T11:53:13Z-
dc.date.available2018-03-05T11:53:13Z-
dc.date.issued2017-
dc.identifier.issn0210-6329-
dc.identifier.urihttp://hdl.handle.net/2445/120433-
dc.description.abstractObjective: To describe the actions taken by the Pharmacy Unit in a tertiary hospital in order to adapt to the recommendations established by NIOSH 2014 for handling Hazardous Drugs. Method: A retrospective observational study. A list was prepared including all hazardous drugs according to NIOSH 2014 that were available at the hospital as marketed or foreign drugs, or used in clinical trials, and there was a review of the processes of acquisition, repackaging, preparation, circuits, organizational, dispensing and identification. Results: After the analysis, a report including all needs was prepared and sent to the Hospital Management. Any relevant information about the handling and administration of hazardous drugs was included in the prescription computer program. There were changes in the acquisition process of two drugs, in order to avoid splitting and multi-dose formulations. An alternative or improvement was found for 35 253 of the 75 779 units of hazardous drugs repackaged in one year. The Pharmacy Unit took over the preparation of four non-sterile medications, as well as the preparation of all sterile parenteral medications included in Lists 1 and 2 that were not previously prepared there, as well as one from List 3. Information was also included about the preparation processes of Magistral Formulations that involved hazardous drugs from Lists 2 or 3.-
dc.format.extent13 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherSociedad Española de Farmacia Hospitalaria-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.7399/fh.2017.41.2.10689-
dc.relation.ispartofFarmacia Hospitalaria, 2017, vol. 41, num. 2, p. 257-269-
dc.relation.urihttps://doi.org/10.7399/fh.2017.41.2.10689-
dc.rights(c) Sociedad Española de Farmacia Hospitalaria, 2017-
dc.sourceArticles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)-
dc.subject.classificationMedicaments-
dc.subject.classificationAvaluació del risc per la salut-
dc.subject.classificationFarmàcies d'hospital-
dc.subject.otherDrugs-
dc.subject.otherHealth risk assessment-
dc.subject.otherHospital pharmacies-
dc.titleImpact of the new handling recommendations for hazardous drugs in a hospital pharmacy service-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec670352-
dc.date.updated2018-03-05T11:53:13Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
670352.pdf290.25 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.